Literature DB >> 1200098

Gyrate atrophy of the choroid and retina with hyperornithinemia.

C McCulloch, E B Marliss.   

Abstract

A case of gyrate atrophy of the choroid and retina and hyperornithinemia in a 28-year-old man was subjected to extensive clinical and biochemical investigation. The familial occurrence of the ocular disease and of abnormality of amino acids was unique to this patient, being absent in parents and siblings. He presented with progressive visual loss, and had cataracts and large areas of peripheral lacumar atrophy. Clinically there was no other abnormality. However, he was hyperuricemic and had an abnormal electroencephalogram. Despite otherwise normal biochemical indices of hepatic, renal, and muscle function, selective catheterization of an artery, the hepatic vein, the renal vein, and a deep forearm vein showed all of these circulatory beds to be producing ornithine according to arteriovenous difference measurements. Cerebrospinal fluid and urine contained increased amounts of ornithine. Though electromyography was normal a muscle biopsy specimen was abnormal. Clinical tests including arginine loading, glucose tolerance testing, and other measurements of blood variables provided inferences as to the metabolic locus of the abnormality. The syndrome is a systemic multiorgan disorder in which the choriod and retina would appear to be target organs and the hyperornithinemia to be of as yet undetermined cause and pathogenic significance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200098     DOI: 10.1016/0002-9394(75)90335-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  OAT mutations and clinical features in two Japanese brothers with gyrate atrophy of the choroid and retina.

Authors:  Satoshi Katagiri; Tamaki Gekka; Takaaki Hayashi; Hiroyuki Ida; Toya Ohashi; Yoshikatsu Eto; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2014-01-16       Impact factor: 2.379

Review 2.  The eye and inherited metabolic disease: a review.

Authors:  A Michalski; J V Leonard; D S Taylor
Journal:  J R Soc Med       Date:  1988-05       Impact factor: 5.344

3.  Free amino acid concentrations in blood cells of two brothers with gyrate atrophy of the choroid and retina with hyperornithinaemia.

Authors:  K Fukuda; Y Nishi; T Usui; H Mishima; H Hirata; S Baba; K Choshi; Y Tanaka; S Akiya
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

4.  Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet.

Authors:  D Valle; M Walser; S W Brusilow; M Kaiser-Kupfer
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina.

Authors:  V E Shih; E L Berson; R Mandell; S Y Schmidt
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

6.  Gyrate atrophy of the choroid and retina: deficiency of ornithine aminotransferase in transformed lymphocytes.

Authors:  D Valle; M I Kaiser-Kupfer; L A Del Valle
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

7.  Gyrate atrophy of the choroid and retina with hyperornithinemia: biochemical and histologic studies and response to vitamin B6.

Authors:  N G Kennaway; R G Weleber; N R Buist
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

Review 8.  Gyrate atrophy of the choroid and retina. Approaches to therapy.

Authors:  R G Weleber; N G Kennaway; N R Buist
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

9.  First reported cases of gyrate atrophy of the choroid from Nepal.

Authors:  Sachet Prabhat Shrestha; Reema Arora; Rajesh Pradhan; Subramaniam Bhatt
Journal:  BMJ Case Rep       Date:  2010-11-29

10.  Gyrate atrophy of the choroid and retina with reticular pigmentary dystrophy and ornithine-ketoacid-transaminase deficiency.

Authors:  A F Deutman; R C Sengers; J M Trybels
Journal:  Int Ophthalmol       Date:  1978-09       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.